Square Medical Group

Research Overview

In 2020, Square Medical Group partnered with McLean Hospital, Harvard Medical School and other community treatment programs across the New England Consortium Node of the National Institutes of Health Clinical Trials Network. We work with the nation’s best academic researchers to conduct innovative research studies and provide no cost, cutting-edge treatments for our patients. If you are interested in learning more about research at Square Medical Group, please email us at RDD@partners.org or call 617-916-5069 ext. 307.

Current Research Projects at Square Medical Group

CTN-0100 RDD Study

Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy

Recruitment starting in June 2021!

This study will 1) test strategies to improve OUD pharmacotherapy treatment retention and to improve outcomes among patients who have been successfully stabilized on OUD medications and want to stop medication; and 2) identify predictors of successful outcome and develop a stage model of relapse risk.

For more information, visit: https://clinicaltrials.gov/ct2/show/NCT04464980

This study is recruiting from the Community as well as the Square Medical Group MAT Program. If you are interested in more information, please email us at RDD@partners.org or call 617-916-5069 ext. 307.